Taixing SynTheAll Pharmaceutical Co., Ltd
FDA inspection history in Taixing, China, 2024
- 1
- Form 483
Every document, by year
- Form 483
2024: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2024One Form 483, at Taixing, China.
Cited most
Across all Taixing SynTheAll Pharmaceutical Co. observations on file
- 21 CFR 211.165Testing and release for distribution1
- 21 CFR 211.186Master production and control records1
- 21 CFR 211.22Responsibilities of quality control unit1
- 21 CFR 211.67Equipment cleaning and maintenance1
- 21 CFR 211.84Testing and approval or rejection of components, drug product containers, and closures1
The complete Taixing SynTheAll Pharmaceutical Co. file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Taixing, China
One Form 483 · 2024 · 5 observations
Latest: Form 483, Sep 27, 2024 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2024-09-27 | 483 Form 483 | Taixing, China | 5 | $99 |
Investigators on these documents
FEI number 3025039932 · most recent document Sep 27, 2024
About Taixing SynTheAll Pharmaceutical Co., Ltd
How many FDA Form 483s has Taixing SynTheAll Pharmaceutical Co., Ltd received?
FDA Intel has 1 Form 483 on file for Taixing SynTheAll Pharmaceutical Co., Ltd; the most recent is dated Sep 27, 2024.
When was Taixing SynTheAll Pharmaceutical Co., Ltd last inspected by FDA?
The most recent FDA inspection document on file for Taixing SynTheAll Pharmaceutical Co., Ltd is a Form 483 dated Sep 27, 2024, for the site in Taixing, China.
What did FDA cite at Taixing SynTheAll Pharmaceutical Co., Ltd?
The regulations cited most in the observations on file for Taixing SynTheAll Pharmaceutical Co., Ltd are 21 CFR 211.165 (Testing and release for distribution), 1 time; 21 CFR 211.186 (Master production and control records), 1 time; 21 CFR 211.22 (Responsibilities of quality control unit), 1 time.